Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion type Assertion NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_head.
- NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion description "[We speculate that engineering GLP-1-Gly8 secretion by beta-cells is a potential gene therapeutic strategy to treat diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_provenance.
- NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion evidence source_evidence_literature NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_provenance.
- NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion SIO_000772 15642594 NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_provenance.
- NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion wasDerivedFrom befree-2016 NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_provenance.
- NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_assertion wasGeneratedBy ECO_0000203 NP475668.RAvcoeFiHCyQClL3xhmvRmIbW83Bp_lsm9Tdsgd4Qo8wI130_provenance.